Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age13-17
SponsorChildren's Mercy Hospital Kansas City

About this trial

The goal of this study is to help teens with Prader-Willi Syndrome (PWS) and their families learn practical strategies for managing issues like irritability, meltdowns, and anxiety. The main objective of the study is:

To adapt current Regulating Together materials to create an outpatient group program for emotion dysregulation in Prader-Willi Syndrome (PWS) that will improve psychosocial outcomes for youth with PWS.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ages 13-17.5 years

Confirmed genetic diagnosis of Prader-Willi Syndrome

Fluent in spoken English

Adolescent's use of flexible phrase speech or greater

Disqualifiers

Initiation of new psychosocial intervention within 30 days prior to first day of treatment

Presence of physical aggression in the adolescent directed towards a peer outside the home that resulted in injury within 30 days prior to screening

Presence of comorbid major neuropsychiatric illness warranting other treatment approaches

Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Trial design

Design model

Single group

Treatments tested in this trial

  • Regulating Together group therapy

    Behavioral

    Regulating Together is the original curriculum developed for autistic youth that uses evidence-based therapeutic strategies including relaxation techniques, parent management training, and mindfulness to help regulate emotions. This study will adapt the original Regulating Together curriculum to focus on behavioral interventions to treat emotion dysregulation in Prader-Willi Syndrome.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Teens with Prader-Willi Syndrome and their caregiverExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Emotion Dysregulation Inventory - Reactivity

The Emotion Dysregulation Inventory consists of two subscales. We will use the Reactivity subscale which captures poorly regulated negative emotional responses and a dysphoria subscale characterized by increased negative affect and lack of motivation. Minimum raw score: 0; Maximum raw score: 96; Higher scores reflect higher emotional reactivity.

Time frame
From enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed

Secondary outcomes

1

Caregiver and Adolescent Readiness and Satisfaction Surveys

We will assess acceptability as reflected in the average caregiver and adolescent satisfaction rating measured using two study-specific measures. Caregivers will complete the Caregiver Readiness and Satisfaction Survey (CRS) and adolescents will complete the Adolescent Readiness and Satisfaction Survey (ARS).

Time frame
From enrollment to end of follow up at 15 weeks
2

Emotion Regulation Skills Test

A child self-report measure created for Regulating Together to measure knowledge of skills taught to manage emotion dysregulation.

Time frame
From enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed
3

Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety and Depression Scales (Parent-Proxy)

Caregiver-report measures to measure change in internalizing symptoms. For both measures: minimum raw value: 13; maximum raw value: 65; higher scores reflect greater anxiety/depression

Time frame
From enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed
4

Aberrant Behavior Checklist, 2nd Edition (ABC-2)

Irritability subscale; a caregiver-report measures to measure change in irritability and related challenging behaviors. Minimum score: 0; Maximum score: 45; higher scores reflect greater irritability

Time frame
From enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Children's Mercy Hospital Kansas City

Lead sponsor

Foundation for Prader-Willi Research

Collaborator